About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBiotech
Clinical Trials (46)
View allTotal Trials
46
As Lead Sponsor
41
As Collaborator
5
Total Enrollment
17,892
By Phase
PHASE2: 19PHASE3: 11PHASE2/PHASE3: 2PHASE1: 11NA: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 31TERMINATED: 7RECRUITING: 4WITHDRAWN: 2NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline46 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07054073Collaborator
HCMR Re-Imaging Study
N/ANot yet recruiting
314 participants
Started: Jul 30, 2025 · Completed: Jul 31, 2026
NCT06793371Lead Sponsor
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
PHASE2Recruiting
60 participants
Started: Feb 6, 2025 · Completed: Sep 30, 2026
NCT06736574Lead Sponsor
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
PHASE3Recruiting
1,800 participants
Started: Dec 19, 2024 · Completed: Dec 31, 2027
NCT06412666Lead Sponsor
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
PHASE2/PHASE3Recruiting
40 participants
Started: May 29, 2024 · Completed: Jan 31, 2030
NCT06081894Lead Sponsor
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM
PHASE3Recruiting
500 participants
Started: Aug 30, 2023 · Completed: Sep 30, 2026
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...